Jonathan Violin - 08 Dec 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Jonathan Violin
Issuer symbol
VRDN
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 17:08:09 UTC
Previous filing
22 Sep 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRDN Common Stock Conversion of derivative security $0 +627,564 +18784% $0.000000 630,905 08 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Series A Non-Voting Convertible Preferred Stock Conversion of derivative security $0 -9,413 -100% $0.000000* 0 08 Dec 2021 Common Stock 627,564 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Non-Voting Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 66.67 shares of Common Stock, subject to certain limitations.

Remarks:

President and Chief Executive Officer Exhibit 24 - Power of Attorney